AP
NEO icon

Arlington Partners’s NeoGenomics NEO Stock Holding History

Arlington Partners’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-108
Closed -$1.74K – 533
2023
Q2 		$1.74K Hold
108
– – ﹤0.01% 544
2023
Q1 		$1.88K Hold
108
– – ﹤0.01% 503
2022
Q4 		$998 Hold
108
– – ﹤0.01% 408
2022
Q3 		$1K Hold
108
– – ﹤0.01% 359
2022
Q2 		$1K Buy
+108
New +$1.03K ﹤0.01% 460

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Arlington Partners's NEO Position: Q3 2023 in Review

Arlington Partners sold out of NeoGenomics (NEO) in Q3 2023, closing a stake of 108 shares — an estimated $1.74K sold.

Arlington Partners first reported a position in NEO in Q2 2022 and held it in 5 quarters. The position peaked at $1.88K in Q1 2023. 283 funds tracked by Wall St. Rank hold NEO as of Q3 2023.

  • Arlington Partners reported no remaining NeoGenomics position as of Q3 2023 after selling out during the quarter.
  • Arlington Partners sold 108 NeoGenomics shares in Q3 2023, an estimated $1.74K.
  • Arlington Partners first reported a position in NeoGenomics in Q2 2022 and held it in 5 quarters.
  • Arlington Partners's NeoGenomics position peaked at $1.88K in Q1 2023.
  • 283 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2023.

Based on Arlington Partners's 13F filing for Q3 2023, filed 24 Oct 2023.